Is TRYPF or ORCC a better dividend investment in 2026?

TRYPF currently yields 3558.72% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: TRYPF offers higher current income.

What is the dividend yield difference between TRYPF and ORCC?

TRYPF has a forward dividend yield of 3558.72% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 3548.93 percentage points.

Home › Compare › TRYPF vs ORCC

TRYPF vs ORCC: Dividend Comparison 2026

TRYPF yields 3558.72% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TRYPF wins by $2329727088831.47M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TRYPF

● Live price

3558.72%

Share price

$0.06

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2329727088831.49M

Annual income

$2,207,692,570,087,591,000.00

Full TRYPF calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — TRYPF vs ORCC

📍 TRYPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TRYPF	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TRYPF + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TRYPF pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRYPF

Annual income on $10K today (after 15% tax)

$302,491.10/yr

After 10yr DRIP, annual income (after tax)

$1,876,538,684,574,452,200.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, TRYPF beats the other by $1,876,538,684,574,452,200.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRYPF + ORCC for your $10,000?

TRYPF: 50%ORCC: 50%

100% ORCC50/50100% TRYPF

Portfolio after 10yr

$1164863544415.75M

Annual income

$1,103,846,285,043,795,500.00/yr

Blended yield

94.76%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

TRYPF

No analyst data

Altman Z

-3902.6

Piotroski

1/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRYPF buys

ORCC buys

No recent congressional trades found for TRYPF or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTRYPFORCC

Forward yield	3558.72% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$2329727088831.49M ✓	$21.4K
Annual income after 10y	$2,207,692,570,087,591,000.00 ✓	$1.04
Total dividends collected	$2321360563920.16M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: TRYPF vs ORCC ($10,000, DRIP)

Year	TRYPF Portfolio	TRYPF Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$366,572	$355,871.89	$11,190	$489.61	+$355.4K → TRYPF
2	$12,584,066	$12,191,834.44	$12,229	$256.01	+$12.57M → TRYPF
3	$404,618,364	$391,153,413.41	$13,216	$130.74	+$404.61M → TRYPF
4	$12,187,002,569	$11,754,060,918.87	$14,207	$66.02	+$12186.99M → TRYPF
5	$343,908,630,433	$330,868,537,684.68	$15,234	$33.17	+$343908.62M → TRYPF
6	$9,094,035,633,286	$8,726,053,398,722.06	$16,317	$16.62	+$9094035.62M → TRYPF
7	$225,379,725,862,498	$215,649,107,734,881.84	$17,468	$8.32	+$225379725.85M → TRYPF
8	$5,236,002,075,601,348	$4,994,845,768,928,476.00	$18,695	$4.16	+$5236002075.58M → TRYPF
9	$114,050,952,097,100,620	$108,448,429,876,207,180.00	$20,006	$2.08	+$114050952097.08M → TRYPF
10	$2,329,727,088,831,488,000	$2,207,692,570,087,591,000.00	$21,407	$1.04	+$2329727088831.47M → TRYPF

TRYPF vs ORCC: Complete Analysis 2026

TRYPF — Stock

Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company's lead development program is (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 and TRP-8803 for fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndrome, and hypothalamic obesity. The company has an agreement with the Calvert Labs to design and execute exploratory studies related to psilocybin-for-neuropsychiatric disorders program; and a service agreement with Fluence to provide design and training for the psychotherapeutic portion of Tryp's clinical trial activities. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. The company was incorporated in 2019 and is based in Kelowna, Canada.

Full TRYPF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this TRYPF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRYPF vs SCHD TRYPF vs JEPI TRYPF vs O TRYPF vs KO TRYPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.